UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000017002
Receipt No. R000019724
Scientific Title Phase 1 trial of Oxaliplatin/IRInotecan/S-1 (OX-IRIS) as first line chemotherapy for unresectable pancreatic cancer
Date of disclosure of the study information 2015/04/01
Last modified on 2018/04/03 09:11:02

No. Disposal Last modified on Item of update
1 Insert 2015/04/01 01:47:42
2 Update 2015/10/25 23:54:21 UMIN ID1
3 Update 2015/10/25 23:58:50 TEL
Email
Last name of contact person
Last name of contact person
TEL
Email
Name of person sending information
Name of person sending information
TEL
Email
4 Update 2015/11/06 21:28:39 Public title
Public title
5 Update 2015/11/06 21:33:56 Narrative objectives1
Primary outcomes
Primary outcomes
6 Update 2015/11/06 21:38:13 Key inclusion criteria
Key exclusion criteria
7 Update 2015/11/06 21:41:01 Recruitment status
Date of protocol fixation
Anticipated trial start date
8 Update 2016/04/01 09:55:57 Name of primary sponsor
Institute
Department
Organization
9 Update 2018/04/03 09:11:02 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete


Contact us.